Results 1 to 10 of about 365,681 (229)
Prostate-Specific Antigen in Prostate Cancer
The International Journal of Biological Markers, 1986 Prostate-specific antigen (PA) has been evaluated clinically as a tumor marker of prostate cancer with the use of enzyme immunoassay (EIA). For serodetection of prostate cancer, PA was assayed in a total of 1,109 sera. From mean ± 3 S.D.
Manabu Kuriyama
doaj +3 more sources
Prostate-Specific Antigen [PDF]
, 2011 The use of PSA as a screening test for prostate cancer remains controversial because no double blind, randomised controlled trial has shown that early detection reduces mortality.1,2 Despite this controversy, PSA provides valuable information for the ...
Brett, Tom
openaire +3 more sources
Journal of Pathology of Nepal, 2022 Background: Prostate-specific antigen density has been suggested to enhance the diagnostic efficacy of serum prostate-specific antigen alone in detecting prostate cancer, thereby reducing unnecessary biopsies and associated morbidities.
Reshmi Shrestha +3 more
doaj +1 more source
Seminars in Surgical Oncology, 2000 Prostate-specific antigen (PSA) has revolutionized the diagnosis and management of men with prostate cancer. Significant advances have been made since the early development of immunoassays. While PSA is useful for staging and monitoring of established disease, it has shown the greatest utility in the realm of early detection realm.
D K, Ornstein, R S, Pruthi
+8 more sources
Asian Journal of Andrology, 2022 The goal of this study was to investigate the clinical application of free/total prostate-specific antigen (F/T PSA) ratio, considering the new broad serum total PSA (T-PSA) “gray zone” of 2.0–25.0 ng ml−1 in differential diagnosis of prostate cancer ...
Xue-Dan Gao +7 more
doaj +1 more source
Body mass index in relation to prostate-specific antigen-related parameters
BMC Urology, 2021 Background Only a few previous studies conducted to assess the association between body mass index (BMI) and prostate-specific antigen (PSA) related parameters have taken prostate volume (PV) and blood volume (BV) into consideration.
Dandan Lin +3 more
doaj +1 more source
Prostatic Specific Antigen in Prostate Cancer
The International Journal of Biological Markers, 1987 Juan Morote, Alvaro Ruibal
doaj +3 more sources
Oncology Reviews, 2020 Prostate-specific antigen velocity (PSAV) is widely used to detect PC and predict its progression. In this study, we qualitatively synthesized the currently available evidence from published studies regarding the PSAV role in PC.
Arslaan Javaeed +3 more
doaj +1 more source
Prostate-Specific Antigen [PDF]
American Journal of Clinical Pathology, 2006 Prostate cancer is a highly prevalent disease that is characterized by a wide range of aggressiveness, ranging from the clinically irrelevant to the rapidly progressive, lethally metastatic. Since its introduction as a serum test in the late 1980s, prostate-specific antigen (PSA) has been increasingly promulgated as an important biomarker for prostate ...
Kristin R. Swanson +2 more
+5 more sources
The Efficiency of the Serum Prostate Specific Antigen Levels in Diagnosing Prostatic Enlargements [PDF]
Journal of Clinical and Diagnostic Research, 2013 Background: The objective of this study was to evaluate the serum PSA levels in patients presenting with enlarged prostate and to evaluate the efficiency of serum PSA to diagnose and differentiate benign and malignant enlargements.
Ingle SP, Ingle Ramona, Sukesh
doaj +1 more source